Cui Zhai

801 total citations
31 papers, 583 citations indexed

About

Cui Zhai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cui Zhai has authored 31 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Cui Zhai's work include Pulmonary Hypertension Research and Treatments (10 papers), Cancer-related molecular mechanisms research (7 papers) and Autophagy in Disease and Therapy (4 papers). Cui Zhai is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Cancer-related molecular mechanisms research (7 papers) and Autophagy in Disease and Therapy (4 papers). Cui Zhai collaborates with scholars based in China and United States. Cui Zhai's co-authors include Manxiang Li, Xin Yan, Wenhua Shi, Qingting Wang, Yanting Zhu, Limin Chai, Jian Wang, Qianqian Zhang, Shaojun Li and Wei Feng and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Investigative Dermatology.

In The Last Decade

Cui Zhai

29 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cui Zhai China 15 276 196 122 85 80 31 583
Xin Yan China 17 384 1.4× 271 1.4× 130 1.1× 128 1.5× 95 1.2× 36 753
Wenhua Shi China 18 407 1.5× 280 1.4× 134 1.1× 152 1.8× 100 1.3× 35 788
Qingting Wang China 17 383 1.4× 293 1.5× 158 1.3× 139 1.6× 98 1.2× 50 803
Eleftheria Letsiou United States 19 404 1.5× 309 1.6× 160 1.3× 85 1.0× 199 2.5× 33 869
Karina A. Serban United States 16 277 1.0× 217 1.1× 53 0.4× 131 1.5× 98 1.2× 37 601
Lili Pan China 15 206 0.7× 288 1.5× 136 1.1× 78 0.9× 143 1.8× 78 737
Poonam Dhillon United States 12 494 1.8× 73 0.4× 144 1.2× 81 1.0× 280 3.5× 13 959

Countries citing papers authored by Cui Zhai

Since Specialization
Citations

This map shows the geographic impact of Cui Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Zhai more than expected).

Fields of papers citing papers by Cui Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cui Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Zhai. The network helps show where Cui Zhai may publish in the future.

Co-authorship network of co-authors of Cui Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Cui Zhai. A scholar is included among the top collaborators of Cui Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cui Zhai. Cui Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Liu, Huan, et al.. (2024). E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway. Journal of Investigative Dermatology. 144(11). 2453–2464.e11. 3 indexed citations
4.
Zhai, Cui, Nana Zhang, Jian Wang, et al.. (2022). Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation. Lung. 200(5). 619–631. 4 indexed citations
5.
Chen, Yuqian, Kai Ye, Li Guo, et al.. (2021). Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples. Frontiers in Cellular and Infection Microbiology. 11. 541092–541092. 94 indexed citations
6.
Zhang, Qianqian, Yanting Zhu, Qingting Wang, et al.. (2021). Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP. Molecular and Cellular Biochemistry. 476(8). 3037–3049. 22 indexed citations
7.
Zhai, Cui, Wei Feng, Wenhua Shi, et al.. (2020). Sphingosine-1-phosphate promotes pulmonary artery smooth muscle cells proliferation by stimulating autophagy-mediated E-cadherin/CDH1 down-regulation. European Journal of Pharmacology. 884. 173302–173302. 11 indexed citations
8.
Wang, Qingting, Wenhua Shi, Qianqian Zhang, et al.. (2019). Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP. Life Sciences. 242. 117159–117159. 16 indexed citations
9.
Li, Shaojun, Cui Zhai, Wenhua Shi, et al.. (2019). Leukotriene B4 induces proliferation of rat pulmonary arterial smooth muscle cells via modulating GSK-3β/β-catenin pathway. European Journal of Pharmacology. 867. 172823–172823. 14 indexed citations
10.
Yan, Xin, Jian Wang, Yanting Zhu, et al.. (2019). S1P induces pulmonary artery smooth muscle cell proliferation by activating calcineurin/NFAT/OPN signaling pathway. Biochemical and Biophysical Research Communications. 516(3). 921–927. 22 indexed citations
11.
Shi, Wenhua, Wei Feng, Jian Wang, et al.. (2019). Clinicopathologic Features and Prognostic Implications of Golgi Phosphoprotein 3 in Non-small Cell Lung Cancer: A Meta-analysis. Journal of Cancer. 10(23). 5754–5763. 4 indexed citations
12.
Shi, Wenhua, Cui Zhai, Wei Feng, et al.. (2018). Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation. Life Sciences. 210. 140–149. 42 indexed citations
13.
Zhu, Yanting, Fangwei Li, Wenhua Shi, et al.. (2018). COP9 signalosome subunit 6 mediates PDGF -induced pulmonary arterial smooth muscle cells proliferation. Experimental Cell Research. 371(2). 379–388. 8 indexed citations
14.
Zhai, Cui, Shaojun Li, Wei Feng, et al.. (2018). Association of interleukin-17a rs2275913 gene polymorphism and asthma risk: a meta-analysis. Archives of Medical Science. 14(6). 1204–1211. 33 indexed citations
15.
Zhai, Cui, Wenhua Shi, Wei Feng, et al.. (2018). Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. Life Sciences. 208. 87–95. 58 indexed citations
16.
Zhu, Yanting, Xin Yan, Cui Zhai, Lan Yang, & Manxiang Li. (2017). Association between risk of asthma and gene polymorphisms in CHI3L1 and CHIA: a systematic meta-analysis. BMC Pulmonary Medicine. 17(1). 193–193. 17 indexed citations
17.
Li, Shaojun, Yilin Pan, Rui Ke, et al.. (2017). Inhibition of phosphodiesterase-5 suppresses calcineurin/NFAT- mediated TRPC6 expression in pulmonary artery smooth muscle cells. Scientific Reports. 7(1). 6088–6088. 13 indexed citations
18.
Li, Fangwei, Yanting Zhu, Yixin Wan, et al.. (2017). Activation of PPARγ inhibits HDAC1-mediated pulmonary arterial smooth muscle cell proliferation and its potential mechanisms. European Journal of Pharmacology. 814. 324–334. 10 indexed citations
19.
Zhang, Yonghong, Xinming Xie, Yanting Zhu, et al.. (2015). Inhibition of Notch3 prevents monocrotaline-induced pulmonary arterial hypertension. Experimental Lung Research. 41(8). 435–443. 18 indexed citations
20.
Xie, Xinming, Jiaojiao Zhang, Cui Zhai, et al.. (2015). Association between Val66Met polymorphisms in brain-derived neurotrophic factor gene and asthma risk: a meta-analysis. Inflammation Research. 64(11). 875–883. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026